Literature DB >> 30058674

MiR-7 regulates the PI3K/AKT/VEGF pathway of retinal capillary endothelial cell and retinal pericytes in diabetic rat model through IRS-1 and inhibits cell proliferation.

Y-L Cao1, D-J Liu, H-G Zhang.   

Abstract

OBJECTIVE: To investigate the role of miR-7 in diabetic retinopathy and the underlying mechanism.
MATERIALS AND METHODS: The rat model of diabetic retinopathy (DR) was established. After that, the endothelial cell (EC) and retinal pericyte (RP) were isolated. QRT-PCR was used to detect the expression of miR-7 and insulin receptor substrate-1 (IRS-1) in ECs and RPs cells while the protein level of IRS1 was detected by Western blot. miR-7 mimic and miR-7 inhibitor were transfected to achieve miR-7 overexpression or knockdown. Cell viability was detected by Cell Counting Kit-8 (CCK-8) assay after miR-7 overexpression or knockdown. Besides, the expression levels of PI3K, AKT, and VEGF were detected by Western Blot. The luciferase reporter assay was performed to investigate whether miR-7 could be combined with IRS-1. Conversely, whether miR-7 could affect IRS-1 was also verified.
RESULTS: miR-7 expression was significantly decreased in ECs and RPs of the experimental group compared with the control group, while the mRNA and protein levels of IRS-1 were increased. The CCK-8 assay showed that overexpression of miR-7 decreased the cell activity in ECs and RPs. In contrast, knock-down of miR-7 could increase the cell viability. Besides, Western blot showed that after overexpression of miR-7, the expressions of PI3K, AKT, and VEGF in ECs and RPs cells were down-regulated. Meanwhile, miR-7 knockdown upregulated the protein levels of PI3K, AKT, and VEGF. The luciferase reporter assay suggested that the 3'UTR region of IRS-1 could be combined with miR-7, which may be the downstream target gene for miR-7. Moreover, knockdown of IRS-1 could reverse the effect of the miR-7 inhibitor on cell proliferation in the diabetic model.
CONCLUSIONS: MiR-7 was lowly expressed in ECs and RPs cells. Overexpression of miR-7 can down-regulate the expression levels of PI3K, AKT, and VEGF by down-regulating its downstream target gene IRS-1, and ultimately inhibit the proliferation of retinal cells.

Entities:  

Year:  2018        PMID: 30058674     DOI: 10.26355/eurrev_201807_15493

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  Effect of Shuangdan Mingmu Capsule on Diabetic Retinopathy in Rats via Regulation of miRNAs.

Authors:  Xiang Li; Yijing Yang; Yan Song; Fujiao Nie; Chaojun Fu; Yuhui Qin
Journal:  Diabetes Metab Syndr Obes       Date:  2022-10-19       Impact factor: 3.249

2.  Elucidating the mechanism of action of alpha-1-antitrypsin using retinal pigment epithelium cells exposed to high glucose. Potential use in diabetic retinopathy.

Authors:  María Constanza Potilinski; Gustavo A Ortíz; Juan P Salica; Emiliano S López; Mariano Fernández Acquier; Eduardo Chuluyan; Juan E Gallo
Journal:  PLoS One       Date:  2020-02-07       Impact factor: 3.240

3.  Downregulation of TAF9B by miR-7-5p Inhibits the Progression of Osteosarcoma.

Authors:  Wanli Gu; Peng Chen; Peng Ren; Yanhai Wang; Xiaobing Li; Mingzhi Gong
Journal:  Onco Targets Ther       Date:  2021-04-30       Impact factor: 4.147

Review 4.  Extracellular vesicles-incorporated microRNA signature as biomarker and diagnosis of prediabetes state and its complications.

Authors:  Nicoleta Alexandru; Anastasia Procopciuc; Alexandra Vîlcu; Ioana Karla Comariţa; Elisabeta Bӑdilӑ; Adriana Georgescu
Journal:  Rev Endocr Metab Disord       Date:  2021-06-18       Impact factor: 6.514

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.